The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
| Title: | The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge |
|---|---|
| Authors: | Nicolini, F.E., Chomel, J.-C., Roy, L., Legros, L., Chabane, K., Ducastelle, S., Nicolas-Virelizier, E., Michallet, M., Tigaud, I., Magaud, J.-P. |
| Source: | CLINICAL LYMPHOMA MYELOMA AND LEUKEMIA. 10(5):394-399 |
| Availability: | http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN281493484&indx=1&recIds=ETOCRN281493484 |
| Database: | British Library Document Supply Centre Inside Serials & Conference Proceedings |
Be the first to leave a comment!